|
J Biol Chem, Vol. 274, Issue 40, 28075-28078, October 1, 1999
COMMUNICATION
p48 (ISGF-3 ) Is Involved in Interferon- -induced
Suppression of Hepatitis B Virus Enhancer-1 Activity
Kazuhiko
Nakao ,
Keisuke
Nakata¶,
Mayumi
Yamashita ,
Youko
Tamada ,
Keisuke
Hamasaki¶,
Hiroki
Ishikawa¶,
Yuji
Kato¶,
Katsumi
Eguchi¶, and
Nobuko
Ishii
From the Health Research Center and the
Department of Clinical Pharmacology, Nagasaki University and the
¶ First Department of Internal Medicine, Nagasaki University
School of Medicine, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan
Interferon- (IFN- ) suppresses hepatitis B
virus (HBV) gene expression by reducing its enhancer-1 activity.
IFN- induces transcription factors, interferon-stimulated gene
factor 3 (ISGF3), and interferon regulatory factor-1 (IRF-1), which
activate interferon-inducible gene expression through binding to the
interferon-stimulated regulatory element (ISRE) "AGTTTCNNTTTCNC" in
the gene promoters. We found the ISRE-like sequence
"AGGCTTTCACTTTCTC" in the HBV enhancer-1 region and elucidated the
role of this sequence. Gel mobility shift assay showed binding of
in vitro translated IRF-1 and in vitro
translated p48 (ISGF3- ), which is a component of ISGF3 to this
sequence. However, nuclear extracts binding to this sequence from human
hepatoma cells (HuH-7) treated with IFN- contained only the protein
consisted of p48. In transfection experiments, IFN- suppressed the
HBV enhancer-1 activity, and overexpression of p48 enhanced this
inhibitory effect. Both mutation and deletion of the ISRE-like sequence
in the HBV enhancer-1 region reduced the suppressive effect of IFN- .
Our results suggest that the ISRE-like sequence in the HBV enhancer-1
can interact with the protein containing p48 and mediate the
IFN- -induced suppression of the enhancer activity.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. F. Alcantara, H. Tang, and A. McLachlan
Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome
Nucleic Acids Res.,
May 1, 2002;
30(9):
2068 - 2075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rang, M. Bruns, T. Heise, and H. Will
Antiviral Activity of Interferon-alpha against Hepatitis B Virus Can Be Studied in Non-hepatic Cells and Is Independent of MxA
J. Biol. Chem.,
March 1, 2002;
277(10):
7645 - 7647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Samuel
Antiviral Actions of Interferons
Clin. Microbiol. Rev.,
October 1, 2001;
14(4):
778 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rang, T. Heise, and H. Will
Lack of a Role of the Interferon-stimulated Response Element-like Region in Interferon alpha -induced Suppression of Hepatitis B Virus in Vitro
J. Biol. Chem.,
January 26, 2001;
276(5):
3531 - 3535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xiao, L. Wang, X. Yang, T. Chen, D. Hodge, P. F. Johnson, and W. Farrar
CCAAT/Enhancer-binding Protein beta Mediates Interferon-gamma -induced p48 (ISGF3-gamma ) Gene Transcription in Human Monocytic Cells
J. Biol. Chem.,
June 22, 2001;
276(26):
23275 - 23281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|